Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) Headache
NCT00258791 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2012-09-25
Summary
The purpose of the study is to determine whether ibuprofen reduces post-ECT headache or reduces its severity.
Conditions
- Mental Disorders
Interventions
- DRUG
Sponsors & Collaborators
-
Norwegian University of Science and Technology
lead OTHER
Principal Investigators
-
Olav Morten Linaker, MD PhD · Norwegian University of Science and Technology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2012-05-31
- Completion
- 2012-05-31
More Related Trials
-
Ibudilast in the Treatment of Medication Overuse Headache
NCT01317992 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache
NCT02485340 ·Status: COMPLETED ·Phase: NA
-
Non-pharmacological Treatments in Migraine.
NCT05596058 ·Status: TERMINATED ·Phase: NA
-
Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction
NCT00487578 ·Status: TERMINATED ·Phase: PHASE4
-
Transcriptomic and Biochemical Changes During a Migraine Attack
NCT02468622 ·Status: COMPLETED
-
Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches
NCT05306899 ·Status: RECRUITING ·Phase: PHASE3
-
Acetaminophen and Ibuprofen With and Without Magnesium and Primary Migraine in Childhood
NCT01756209 ·Status: COMPLETED ·Phase: PHASE4
-
Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan
NCT01989936 ·Status: COMPLETED ·Phase: PHASE3
-
Hypersensitivity to Opening of ATP-Sensitive Potassium Channels in Post-Traumatic Headache
NCT05243953 ·Status: COMPLETED ·Phase: NA
-
EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model
NCT00957983 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Ketamine for Acute Migraine in the Emergency Department
NCT02697071 ·Status: COMPLETED ·Phase: NA
-
Hypersensitivity to Phosphodiesterase 5 Inhibition in Post-Traumatic Headache
NCT05669885 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of a Novel App-based Migraine Treatment Platform - a Pilot Study
NCT04106505 ·Status: TERMINATED ·Phase: NA
-
Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine
NCT01978496 ·Status: COMPLETED ·Phase: PHASE3
-
Hypersensitivity to Phosphodiesterase 3 Inhibition in Post-Traumatic Headache
NCT05595993 ·Status: UNKNOWN ·Phase: NA
-
Effect of Acetyl-L-carnitine in Migraine
NCT01695317 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Sumatriptan and Placebo Injection on Cilostazol Induced Headache
NCT03422796 ·Status: COMPLETED ·Phase: NA
-
Hypersensitivity to Opening of BKCa Channels in Post-Traumatic Headache
NCT05378074 ·Status: UNKNOWN ·Phase: NA
-
Study on Indomethacin-responsive Headaches
NCT03967483 ·Status: UNKNOWN
-
A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)
NCT00758836 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache
NCT02486276 ·Status: COMPLETED ·Phase: NA
-
Ibudilast in the Treatment of Patients With Chronic Migraine.
NCT01389193 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine
NCT05211050 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Tolerability, and Safety of DFN-15
NCT03009019 ·Status: COMPLETED ·Phase: PHASE3
-
Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?
NCT00159588 ·Status: COMPLETED ·Phase: NA